1h Free Analyst Time
The dPCR & qPCR Market size was estimated at USD 8.05 billion in 2023, USD 8.88 billion in 2024, and is expected to grow at a CAGR of 10.23% to reach USD 15.94 billion by 2030. Speak directly to the analyst to clarify any post sales queries you may have.
Digital PCR (dPCR) refers to a measurement technique that provides an absolute quantification of target nucleic acids by partitioning the reaction. Quantitative PCR (qPCR), also known as real-time PCR, is a technique that enables the continuous monitoring of the PCR reaction as it progresses. It involves using fluorescent reporter molecules to quantify the amount of amplified nucleic acids in real-time. dPCR and qPCR enable rapid DNA amplification and quantification necessary for a wide range of applications, including genotyping, gene expression analysis, viral load determination, and validation of high-throughput sequencing data. The rising prevalence of infectious diseases has necessitated the deployment of advanced diagnostics procedures to ensure fast and efficient disease detection. Increased funding for genomics research projects from public & private organizations and the growing need for personalized diagnostics and therapeutic options has further boosted the adoption of PCR technologies. However, the initial investment for acquiring advanced instrumentation required for PCR can be a significant economic barrier for some organizations. Furthermore, analyzing high-dimensional data generated by dPCR & qPCR experiments requires specialized bioinformatics tools & the lack of expertise might impede the widespread adoption of dPCR and qPCR. Efforts by the government and established players to expand access to training programs for PCR technology can overcome such challenges. Technological advancements in PCR technologies and continuous research & development efforts have expanded the growth of dPCR and qPCR technology.
Regional Insights
In the Americas region, the demand for dPCR and qPCR is driven primarily by advancements in life sciences research, diagnostics, and pharmacogenomics. The United States has a well-established pharmaceutical industry that invests heavily in research & development activities. A strong focus on precision medicine initiatives also contributes to increased adoption. In Europe, there is an increasing number of diagnostic centers that frequently utilize advanced PCR technologies. Germany, France, and the UK also invest heavily in molecular diagnostics. Higher government spending on healthcare infrastructure and stringent regulations concerning food safety have driven the adoption of dPCR and qPCR in European nations. Rapidly growing economies in the APAC region, particularly China and India, are investing in their healthcare infrastructure to tackle the rising incidences of disease outbreaks and epidemics. Growing awareness about advanced molecular diagnostic platforms such as dPCR/qPCR among researchers, coupled with their increasing affordability, has contributed significantly towards their acceptance across the APAC region.FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the dPCR & qPCR Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the dPCR & qPCR Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.Key Company Profiles
The report delves into recent significant developments in the dPCR & qPCR Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Abbott Laboratories, accela s.r.o., Agilent Technologies, Inc., Analytik Jena GmbH, Becton Dickinson and Company, Bio-Rad Laboratories, Inc., BioMed Central Ltd, BioMérieux S.A., Canopy Biosciences, LLC, Combinati Inc., Danaher Corporation, F. Hoffman-La Roche Ltd., GE Healthcare Inc., JN Medsys Pte. Ltd., Merck KGaA, PerkinElmer, Inc., Pfizer Inc., Promega Corporation, QIAGEN N.V. by Thermo Fisher Scientific, Inc., Roche Holding AG, Siemens Healthineers AG, Stilla Technologies SA, Takara Bio Inc., and Vela Diagnostics.Market Segmentation & Coverage
This research report categorizes the dPCR & qPCR Market to forecast the revenues and analyze trends in each of the following sub-markets:- Product
- Instruments
- Reagents & Consumables
- Software & Services
- Application
- Clinical Application
- Blood Screening
- Oncology Testing
- Pathogen Testing
- Forensic Applications
- Research Application
- Clinical Application
- End-User
- Academic Research & Institutes
- Contract Research Organizations
- Hospitals & Care Providers
- Pharmaceutical & Biotechnology Companies
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
- What is the market size and forecast of the dPCR & qPCR Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the dPCR & qPCR Market?
- What are the technology trends and regulatory frameworks in the dPCR & qPCR Market?
- What is the market share of the leading vendors in the dPCR & qPCR Market?
- Which modes and strategic moves are suitable for entering the dPCR & qPCR Market?
Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.
This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.
Table of Contents
1. Preface
2. Research Methodology
4. Market Overview
5. Market Insights
6. dPCR & qPCR Market, by Product
7. dPCR & qPCR Market, by Application
8. dPCR & qPCR Market, by End-User
9. Americas dPCR & qPCR Market
10. Asia-Pacific dPCR & qPCR Market
11. Europe, Middle East & Africa dPCR & qPCR Market
12. Competitive Landscape
13. Competitive Portfolio
14. Appendix
List of Figures
List of Tables
Companies Mentioned
- 10x Genomics, Inc.
- Abbott Laboratories
- accela s.r.o.
- Agilent Technologies, Inc.
- Analytik Jena GmbH
- Becton Dickinson and Company
- Bio-Rad Laboratories, Inc.
- BioMed Central Ltd
- BioMérieux S.A.
- Canopy Biosciences, LLC
- Combinati Inc.
- Danaher Corporation
- F. Hoffman-La Roche Ltd.
- GE Healthcare Inc.
- JN Medsys Pte. Ltd.
- Merck KGaA
- PerkinElmer, Inc.
- Pfizer Inc.
- Promega Corporation
- QIAGEN N.V. by Thermo Fisher Scientific, Inc.
- Roche Holding AG
- Siemens Healthineers AG
- Stilla Technologies SA
- Takara Bio Inc.
- Vela Diagnostics
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 188 |
| Published | March 2024 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 8.88 Billion |
| Forecasted Market Value ( USD | $ 15.94 Billion |
| Compound Annual Growth Rate | 10.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
